Arjowiggins Healthcare Launches Cryptopak Security Solution

An image of a surface structure is scanned to derive a signature unique to each package.
Arjowiggins Healthcare ( has introduced an authentication solution for medical device and pharmaceutical packaging based on the randomness and uniqueness of package material substrates.
First revealed at Medica 2012, Cryptopak provides packagers with a covert security solution that is impossible to forge, says Frederic Olivesi-Demarque, marketing and sales development director,
Arjowiggins Healthcare.
“With Cryptopak, packagers have a solution that is easily implemented, and at a minimal cost as it does not require package redesign,” Olivesi-Demarque says.
Cryptopak was developed by the Arjowiggins Group security division as a technology for securing sensitive assets and high value products. The Royal Mint of Canada is among users of the solution.
In launching the technology for the health industry, Arjowiggins Healthcare established its suitability for medical packaging lines running porous substrates.
The system uses an Arjowiggins camera with built-in software that optically scans the substrate at a designated spot on the package.
The captured image of the material’s structure is encrypted with a signature unique to each package. The image could be taken on an art element such as a logo or at any other printed area of the substrate.
The process takes place on the printed substrate at the printing station or just after the printing station on the packaging supplier’s or the packager’s lines.
Codes are stored in a database that can be Arjowiggins Healthcare operated or maintained at the converter or the packager for reference when hand-held scanners are used to confirm the codes.
A key advantage of Cryptopak is that it can be flexibly deployed on products and lines, as there is no change to package design, substrate, or packaging content.
“Cryptopak enables a universal solution that gives companies different options. You can run it as a one shot on a limited number of products,” Olivesi-Demarque says.
“Or alternately, encode 100% of production. A customer may want to track a product line if there are concerns over breached distribution agreements,” he adds.
The system works with any substrate that presents random distribution of material on the surface, including paper, foil, and Tyvek. “Films and fully transparent materials are more complicated as it becomes more difficult to capture surface contrasts,” he says.
The solution can be used to ensure pharmaceutical or medical device sales are moving through approved channels, and for discovering counterfeits in non-genuine packaging. Additionally, it guards against unauthorized changes by suppliers of materials. 
“Customers will have many different policies on handling package verification. Typically, a very limited number of people are charged with maintaining product safety. Firms may be sending people into the field, or checking product returned to the manufacturer,” Olivesi-Demarque says.
Cryptopak has the most potential as an easy and secure way to protect critical high value product such as pace makers and other invasive devices, prefilled syringes, and
combinations, Olivesi-Demarque says.
“Companies can also introduce safety in new markets, where Cryptopak tracking might run for a period of time until there is confidence in the distribution channels,”
Olivesi-Demarque adds.
Arjowiggins Healthcare is a subsidiary of the Arjowiggins Group, which is a global producer of
technical papers.
No votes yet